CHCigdem Hopa

Cigdem Hopa

*This is an algorithmically generated author record based on publicly available information.

Cigdem Hopa has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synthesis, Characterization and In Vitro Antiproliferative Evaluation of Novel Copper(II) and Nickel(II) Dicyanamido Complexes Containing Propane-1,3-Diamine Derivatives

    by İlKay Erdurmazli, Hazal Naz Turkmen, Hatice Yildirim, Elif Gungor, Cigdem Hopa

    Cisplatin and other platinum-based compounds have played a central role in the treatment of various cancers; however, their clinical applications are limited by dose-dependent toxicity and the development of drug resistance. These limitations have stimulated extensive research into alternative metal-based compounds with diverse coordination environments and potentially improved biological profiles. In this study, three novel Cu(II) and Ni(II) coordination complexes, [Cu₂(DAP-OH)(CH₃COO)(dca)₂]ₙ (1), [Ni(DAP-DM)₂(dca)₂] (2), and [Ni(DAP)₂(dca)₂] (3), containing 2-hydroxypropane-1,3-diamine (DAP-OH), 2,2-dimethylpropane-1,3-diamine (DAP-DM), propane-1,3-diamine (DAP), and dicyanamide (dca) ligands, have been synthesized and characterized by elemental analysis, FT-IR spectroscopy, and single-crystal X-ray diffraction analysis. The antiproliferative activities of the complexes were evaluated in vitro against Hep3B, PC-3, SW480, and HUVEC cell lines using the MTT assay. Among the investigated compounds, the copper-containing complex 1 exhibited the most pronounced cytotoxic activity, particularly against Hep3B cells. At 100 µM, complex 1 reduced cell viability below 50% in Hep3B, PC-3, and HUVEC cells, whereas a less pronounced effect was observed in SW480 cells. At 10 µM, complex 1 preferentially reduced Hep3B cell viability, while complexes 2 and 3 exhibited limited cytotoxic effects. Furthermore, treatment with 10 µM complex 1 significantly suppressed the colony-forming capacity of Hep3B cells, whereas no significant effect on cell migration was observed in the wound-healing assay. Overall, the combined structural and biological findings demonstrate that the newly synthesized Cu(II) and Ni(II) complexes possess distinct structure–activity profiles, with complex 1 emerging as a promising candidate for further investigation in non-platinum metal-based anticancer research.